Literature DB >> 12773344

Field-delivered therapy increases treatment for chlamydia and gonorrhea.

Katherine C Steiner1, Veronica Davila, Charlotte K Kent, Janice K Chaw, Lyn Fischer, Jeffrey D Klausner.   

Abstract

In 1998, treatment completion was low among chlamydia and gonorrhea cases reported to the San Francisco Department of Public Health and assigned for treatment follow-up. To improve treatment completion among growing numbers of chlamydia and gonorrhea cases, the department implemented field-delivered therapy (FDT), a single-dose, directly observed therapy protocol for uncomplicated chlamydial and gonococcal infections. After the protocol was implemented in March 1999, the proportion of cases completing treatment increased significantly, from 61.8% in 1998 to 81.0% in 2000. The greatest increases in treatment completion were observed for females and individuals younger than 20 years old. FDT is an effective, feasible, and convenient way to reach and treat individuals who are unlikely to return for chlamydia and gonorrhea treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773344      PMCID: PMC1447859          DOI: 10.2105/ajph.93.6.882

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

1.  What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic?

Authors:  Eline L Korenromp; Mondastri K Sudaryo; Sake J de Vlas; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Maria J Wawer; J Dik F Habbema
Journal:  Int J STD AIDS       Date:  2002-02       Impact factor: 1.359

Review 2.  Genital chlamydial infections: epidemiology and reproductive sequelae.

Authors:  W Cates; J N Wasserheit
Journal:  Am J Obstet Gynecol       Date:  1991-06       Impact factor: 8.661

Review 3.  From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.

Authors:  D T Fleming; J N Wasserheit
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

Review 4.  Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel.

Authors:  C P Chaulk; V A Kazandjian
Journal:  JAMA       Date:  1998-03-25       Impact factor: 56.272

5.  Pelvic inflammatory disease: etiology, diagnosis, and treatment.

Authors:  R L Sweet
Journal:  Sex Transm Dis       Date:  1981 Oct-Dec       Impact factor: 2.830

  5 in total
  12 in total

1.  "Street medicine": Collaborating with a faith-based organization to screen at-risk youths for sexually transmitted diseases.

Authors:  Nicholas J Moss; Alonzo Gallaread; Jacqueline Siller; Jeffrey D Klausner
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

2.  Improving care for urban children with asthma: design and methods of the School-Based Asthma Therapy (SBAT) trial.

Authors:  Jill S Halterman; Belinda Borrelli; Susan Fisher; Peter Szilagyi; Lorrie Yoos
Journal:  J Asthma       Date:  2008-05       Impact factor: 2.515

3.  Time to treatment for women with chlamydial or gonococcal infections: a comparative evaluation of sexually transmitted disease clinics in 3 US cities.

Authors:  David Wong; Stuart M Berman; Bruce W Furness; Robert A Gunn; Melanie Taylor; Thomas A Peterman
Journal:  Sex Transm Dis       Date:  2005-03       Impact factor: 2.830

4.  Knowledge of sex partner treatment for past bacterial STI and risk of current STI.

Authors:  L M Niccolai; J R Ickovics; K Zeller; T S Kershaw; S Milan; J B Lewis; K A Ethier
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

5.  Impact of Check It: A Novel Community-Based Chlamydia Screening and Expedited Treatment Program for Young Black Men.

Authors:  Charles Stoecker; Yixue Shao; Norine Schmidt; David H Martin; Patricia J Kissinger
Journal:  Sex Transm Dis       Date:  2022-01-01       Impact factor: 2.830

Review 6.  Expedited partner therapy for sexually transmitted infections.

Authors:  Matthew Hogben; Sarah Kidd; Gale R Burstein
Journal:  Curr Opin Obstet Gynecol       Date:  2012-10       Impact factor: 1.927

Review 7.  Partner Services in Sexually Transmitted Disease Prevention Programs: A Review.

Authors:  Matthew Hogben; Dayne Collins; Brooke Hoots; Kevin OʼConnor
Journal:  Sex Transm Dis       Date:  2016-02       Impact factor: 2.830

8.  Adolescent Sexually Transmitted Diseases: Recent Developments.

Authors:  Diane R. Blake
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

9.  Safety and Effectiveness of Same-Day Chlamydia trachomatis and Neisseria gonorrhoeae Screening and Treatment Among Gay, Bisexual, Transgender, and Homeless Youth in Los Angeles, California, and New Orleans, Louisiana.

Authors:  Erin M Keizur; Cameron Goldbeck; Gabriella Vavala; Adriana Romero-Espinoza; Manuel Ocasio; Jasmine Fournier; Sung-Jae Lee; Sue-Ellen Abdalian; Mary Jane Rotheram; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2020-01       Impact factor: 3.868

10.  Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.

Authors:  Jeffrey D Klausner; Claire C Bristow; Olusegun O Soge; Akbar Shahkolahi; Toni Waymer; Robert K Bolan; Susan S Philip; Lenore E Asbel; Stephanie N Taylor; Leandro A Mena; Deborah A Goldstein; Jonathan A Powell; Michael R Wierzbicki; Sheldon R Morris
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.